Production (Stage)
Allarity Therapeutics, Inc.
ALLR
$1.03
-$0.035-3.29%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -88.86% | -105.99% | -44.30% | 14.45% | 24.12% |
| Total Depreciation and Amortization | -37.93% | -75.68% | -43.33% | -34.38% | -38.30% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 283.83% | 269.62% | 354.53% | -128.56% | -476.39% |
| Change in Net Operating Assets | -152.47% | -98.15% | -145.47% | -69.74% | 105.59% |
| Cash from Operations | -69.52% | -35.46% | -16.35% | -24.79% | 23.28% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -100.00% | 27.62% | -34.63% | -34.63% | 139.00% |
| Total Debt Repaid | 63.77% | 63.77% | 63.74% | 49.49% | -- |
| Issuance of Common Stock | 152.67% | 95.18% | 80.73% | 487.12% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | 153.28% | 153.28% | -100.00% | -100.00% |
| Repurchase of Preferred Stock | 47.38% | 47.40% | 47.40% | -202.30% | -332,500.00% |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 315.04% | 234.62% | 188.32% | 590.05% | 7,431.37% |
| Foreign Exchange rate Adjustments | -22.18% | 221.24% | 40.99% | -164.01% | -238.92% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 161,029.41% | 1,139.56% | 769.96% | 359.24% | 100.12% |